Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cannabist Company HoldingsCBSTQ -50.00% EV-to-EBITDA is -8.64 as of Jul. 27, 2026. The stock has 3 warning signs investors should review. Among 742 Drug Manufacturers companies, Cannabist Company Holdings ranks worse than 134770.75% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cannabist Company Holdings's enterprise value is $424.1 Mil.
Cannabist Company Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $-49.1 Mil. Therefore, Cannabist Company Holdings's EV-to-EBITDA for today is -8.64.
The historical rank and industry rank for Cannabist Company Holdings's EV-to-EBITDA or its related term are showing as below:
CBSTQ'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -76.91 Med: -9.17 Max: 156.45
Current: -8.64
During the past 7 years, the highest EV-to-EBITDA of Cannabist Company Holdings was 156.45. The lowest was -76.91. And the median was -9.17.
CBSTQ's EV-to-EBITDA is ranked worse than 100% of 742
companies
in the Drug Manufacturers industry
Industry Median: 12.93
vs CBSTQ: -8.64
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Cannabist Company Holdings (OTCPK:CBSTQ) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cannabist Company Holdings's PE Ratio (TTM) for today is calculated as:
Cannabist Company Holdings's share price for today is $0.0001.
Cannabist Company Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.380.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CBSTQ vs OWPC, AYURF, PNXP: EV-to-EBITDA Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabist Company Holdings EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cannabist Company Holdings's EV-to-EBITDA falls into.
Cannabist Company Holdings's current Enterprise Value is $424.1 Mil.
Cannabist Company Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-49.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabist Company Holdings (CBSTQ) has a EV-to-EBITDA of -8.64 as of Jul. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cannabist Company Holdings. According to the industry distribution chart, Cannabist Company Holdings ranks #999999 out of 742 companies in the Drug Manufacturers industry.
Is Cannabist Company Holdings' EV-to-EBITDA too high?
Cannabist Company Holdings' current EV-to-EBITDA is -8.64. Based on the distribution chart, Cannabist Company Holdings ranks #999999 out of 742 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Cannabist Company Holdings' EV-to-EBITDA compare to OWPC and AYURF?
According to the Drug Manufacturers industry distribution chart, Cannabist Company Holdings ranks #999999 out of 742 companies for EV-to-EBITDA. This places Cannabist Company Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 12.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 12.93, based on 742 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cannabist Company Holdings. For the Drug Manufacturers industry, the median EV-to-EBITDA is 12.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabist Company Holdings's current EV-to-EBITDA is -8.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabist Company Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cannabist Company Holdings (CBSTQ) is currently considered Possible Value Trap. The stock's GF Value™ is $0.15, compared to a current price of $0.00 — trading 99.9% below its estimated fair value. The current EV-to-EBITDA is -8.64. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Cannabist Company Holdings (CBSTQ), the current EV-to-EBITDA is -8.64 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBSTQ has been successfully added to your 
